By drug type, the branded semaglutide segment captured the biggest market share of 95% in 2024
If dose flexibility is allowed to manage early gastrointestinal adverse events, why not to apply the same approach for less common but still possible late adverse events associated with either excessive or too fast weight loss
Lawsuits have accused Novo Nordisk of failing to warn about dangerous side effects associated with Ozempic, Wegovy, and Rybelsus, Lawsuits have also named Eli Lilly based on similar allegations involving Trulicity and Mounjaro
Authored by: Sergey Terushkin, MD, FACS, FASMBS, DABOM, DABS-FPMBS Key Takeaways The liver is the bodys powerhouse, playing a critical role in metabolism, detoxification, and energy storage
ii) Modulating autophagy to overcome drug resistance
However, numerous carcinogenic factors still need to be explored through further research